Michael E. Klepser

5.6k total citations
135 papers, 4.4k citations indexed

About

Michael E. Klepser is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Michael E. Klepser has authored 135 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 63 papers in Infectious Diseases and 35 papers in Pharmacology. Recurrent topics in Michael E. Klepser's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Antifungal resistance and susceptibility (30 papers) and Pneumonia and Respiratory Infections (23 papers). Michael E. Klepser is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Antifungal resistance and susceptibility (30 papers) and Pneumonia and Respiratory Infections (23 papers). Michael E. Klepser collaborates with scholars based in United States, Belgium and South Africa. Michael E. Klepser's co-authors include Erika J. Ernst, Michael A. Pfaller, Russell E. Lewis, Michael E. Ernst, Teresa Bailey Klepser, Donald G. Klepser, Alex J. Adams, Erika J. Wolfe, Stephanie A. Klepser and Allison M. Dering-Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael E. Klepser

132 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Klepser United States 37 2.0k 1.7k 847 555 478 135 4.4k
Erika J. Ernst United States 28 1.3k 0.7× 1.0k 0.6× 603 0.7× 356 0.6× 267 0.6× 71 2.7k
John A. Bosso United States 30 794 0.4× 933 0.5× 1.3k 1.6× 157 0.3× 688 1.4× 120 3.7k
Iruka N. Okeke Nigeria 38 1.4k 0.7× 886 0.5× 361 0.4× 360 0.6× 1.6k 3.4× 140 6.3k
Annalisa Pantosti Italy 38 2.3k 1.2× 1.8k 1.1× 540 0.6× 274 0.5× 825 1.7× 154 6.7k
I.M. Gould United Kingdom 32 1.0k 0.5× 728 0.4× 676 0.8× 123 0.2× 1.2k 2.5× 93 3.4k
María Virginia Villegas Colombia 40 841 0.4× 949 0.6× 1.0k 1.2× 174 0.3× 1.5k 3.1× 129 5.4k
Didier Guillemot France 39 1.3k 0.7× 2.3k 1.3× 443 0.5× 86 0.2× 1.2k 2.5× 167 5.0k
Luke Moore United Kingdom 34 1.7k 0.8× 1.3k 0.8× 523 0.6× 120 0.2× 2.6k 5.4× 142 6.3k
Melissa D. Johnson United States 29 2.1k 1.1× 1.9k 1.1× 256 0.3× 166 0.3× 214 0.4× 92 3.3k
Sabiha Y. Essack South Africa 36 837 0.4× 574 0.3× 398 0.5× 137 0.2× 1.2k 2.4× 199 4.5k

Countries citing papers authored by Michael E. Klepser

Since Specialization
Citations

This map shows the geographic impact of Michael E. Klepser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Klepser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Klepser more than expected).

Fields of papers citing papers by Michael E. Klepser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Klepser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Klepser. The network helps show where Michael E. Klepser may publish in the future.

Co-authorship network of co-authors of Michael E. Klepser

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Klepser. A scholar is included among the top collaborators of Michael E. Klepser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Klepser. Michael E. Klepser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klepser, Donald G., et al.. (2024). Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead. Research in Social and Administrative Pharmacy. 20(6). 146–151. 3 indexed citations
2.
Adams, Alex J., Donald G. Klepser, & Michael E. Klepser. (2024). State Variation in Uptake of Pharmacy-Based CLIA-Waived Testing: Impact of Laws and Regulations. Journal of Pharmacy Technology. 41(2). 95–99.
3.
Klepser, Donald G., et al.. (2023). COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice. Research in Social and Administrative Pharmacy. 19(10). 1360–1364. 2 indexed citations
4.
Klepser, Michael E., et al.. (2023). Community pharmacist‐provided test and treat programs for acute infectious conditions. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(9). 1030–1040. 4 indexed citations
5.
Hohmeier, Kenneth C., et al.. (2022). Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement. SHILAP Revista de lepidopterología. 3(1). 77–77. 9 indexed citations
6.
Klepser, Donald G., et al.. (2020). Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities. Research in Social and Administrative Pharmacy. 17(9). 1574–1578. 24 indexed citations
7.
Adams, Alex J., et al.. (2018). Review of Pharmacy-Based Management of Uncomplicated Urinary Tract Infections (UTIS) In Community Pharmacy Settings. International Journal of Pharmacy. 8(28). 63–69. 9 indexed citations
8.
Adams, Alex J., Allison M. Dering-Anderson, Michael E. Klepser, & Donald G. Klepser. (2017). The Roles of Pharmacy Schools in Bridging the Gap Between Law and Practice. American Journal of Pharmaceutical Education. 82(4). 6577–6577. 11 indexed citations
9.
Gubbins, Paul O., et al.. (2016). Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases. Journal of Public Health Management and Practice. 23(6). 593–600. 27 indexed citations
10.
11.
Huang, Vanthida, Michael E. Klepser, Paul O. Gubbins, et al.. (2015). Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharmacy Education. 15(1). 1–6. 4 indexed citations
12.
Klepser, Michael E., Alex J. Adams, & Donald G. Klepser. (2015). Antimicrobial Stewardship in Outpatient Settings: Leveraging Innovative Physician-Pharmacist Collaborations to Reduce Antibiotic Resistance. Health Security. 13(3). 166–173. 62 indexed citations
13.
Klepser, Michael E.. (2014). Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines. Drugs. 74(13). 1467–1479. 52 indexed citations
14.
Klepser, Michael E., et al.. (2010). Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis. SHILAP Revista de lepidopterología. 1 indexed citations
15.
VandenBussche, Heather L., et al.. (2006). Pertussis Resurgence: Diagnosis, Treatment, Prevention, and Beyond. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(1). 41–52. 26 indexed citations
16.
Ernst, Erika J., et al.. (2000). Novel triazole antifungal agents. Expert Opinion on Investigational Drugs. 9(3). 593–605. 104 indexed citations
17.
Klepser, Michael E., Erika J. Ernst, Michael E. Ernst, & Michael A. Pfaller. (1997). Growth medium effect on the antifungal activity of LY 303366. Diagnostic Microbiology and Infectious Disease. 29(4). 227–231. 24 indexed citations
18.
Ernst, Michael E., et al.. (1997). Tetanus: Pathophysiology and Management. Annals of Pharmacotherapy. 31(12). 1507–1513. 33 indexed citations
19.
Nicolau, David P., Mary Anné Banevicius, Markos Marangos, et al.. (1997). Influence of adjunct azithromycin on the mortality of experimental Pseudomonas aeruginosa sepsis. International Journal of Antimicrobial Agents. 8(4). 239–241. 4 indexed citations
20.
Klepser, Michael E. & Teresa Bailey Klepser. (1997). Drug Treatment of HIV-Related Opportunistic Infections. Drugs. 53(1). 40–73. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika J. Ernst Breakdown of academic impact, for papers by John A. Bosso Breakdown of academic impact, for papers by Iruka N. Okeke Breakdown of academic impact, for papers by Annalisa Pantosti Breakdown of academic impact, for papers by I.M. Gould Breakdown of academic impact, for papers by María Virginia Villegas Breakdown of academic impact, for papers by Didier Guillemot Breakdown of academic impact, for papers by Luke Moore Breakdown of academic impact, for papers by Melissa D. Johnson Breakdown of academic impact, for papers by Sabiha Y. Essack
Rankless by CCL
2026